Modifying NICE’s approach to equity weighting

7 February 2021 - The UK’s NICE recently launched a consultation on the methods it uses to evaluate new health technologies, ...

Read more →

Vaccine distribution—equity left behind?

29 January 2021 - Over the past 2 weeks numerous US states have announced a major shift in coronavirus disease ...

Read more →

Big Pharma’s new CEOs must step up to erase inequities in drug access

16 December 2020 - I have been asked many times: Does the vision of the CEO have the power to ...

Read more →

PHARMAC funding resources to focus on medicines access equity

3 November 2020 - PHARMAC is pleased to announce the launch of He Ako Hiringa, a clinical education provider with ...

Read more →

Access to the latest and most effective diabetes drugs depends on where you live and what you earn

21 October 2020 - Access to the latest and most effective drugs for Australians with diabetes can depend on where ...

Read more →

COVID-19 vaccines: time to talk about the uncertainties

20 October 2020 - Plan now for decisions on which vaccines should go to whom, when and how often. ...

Read more →

Countries pledge nearly US$1 billion to support equitable access to COVID-19 vaccines

6 October 2020 - Gavi, the Vaccine Alliance has welcomed pledges made this week in support of the Gavi COVAX AMC, ...

Read more →

Rare Disorders New Zealand supports Human Rights Commission case against PHARMAC

17 September 2020 - Rare Disorders New Zealand supports patient advocate Fiona Tolich’s Human Rights Commission case against PHARMAC for ...

Read more →

A proposed lottery system to allocate scarce COVID-19 medications: promoting fairness and generating knowledge

28 July 2020 - On May 1, 2020, the US FDA issued an Emergency Use Authorization for the unapproved drug remdesivir ...

Read more →

PHARMAC report: should rich people get subsidised medicine?

29 July 2020 - Should wealthy New Zealanders have access to subsidised medicines when they could be investing in better ...

Read more →

Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers

 3 July 2020 - The US has bought up almost all the world’s supply of the antiviral drug remdesivir in ...

Read more →

It’s time to put fairness into focus

19 June 2020 - Medicines New Zealand is today launching a digitally-enabled public awareness platform Fairness in Focus.  ...

Read more →

The equitable distribution of COVID-19 therapeutics and vaccines

7 May 2020 - Scientists from across the globe are racing to develop effective vaccines and therapeutics for COVID-19.  ...

Read more →

The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?

10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication.  ...

Read more →

ALP cancer plan ‘divisive, inequitable’

11 April 2019 - Labor’s decision to prioritise fee relief for cancer patients is a departure from its previous policies ...

Read more →